BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31769584)

  • 1. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
    Modi A; Rybicki L; Majhail NS; Mossad SB
    Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of Gut Microbiota Composition and Diversity in Acute and/or Chronic Graft-versus-Host Disease Following Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study.
    Gavriilaki E; Christoforidi M; Ouranos K; Minti F; Mallouri D; Varelas C; Lazaridou A; Baldoumi E; Panteliadou A; Bousiou Z; Batsis I; Sakellari I; Gioula G
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, Etiology, Risk Factors, and Outcomes of Bloodstream Infection after a Second Hematopoietic Stem Cell Transplantation.
    Ohta T; Ueno T; Uehara Y; Yokoyama T; Nakazawa M; Sato Y; Uchida Y; Ohno Y; Sugio Y
    Intern Med; 2023 Nov; 62(22):3305-3316. PubMed ID: 37032079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical value of anal swabs for microbial detection in allogeneic haematopoietic stem cell transplantation.
    Gao J; Lin D; Hou C; Shen Y; Li Y; Wu D; Xu Y
    Transplant Cell Ther; 2023 Oct; 29(10):619.e1-619.e9. PubMed ID: 37499872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.
    Shono Y; Docampo MD; Peled JU; Perobelli SM; Velardi E; Tsai JJ; Slingerland AE; Smith OM; Young LF; Gupta J; Lieberman SR; Jay HV; Ahr KF; Porosnicu Rodriguez KA; Xu K; Calarfiore M; Poeck H; Caballero S; Devlin SM; Rapaport F; Dudakov JA; Hanash AM; Gyurkocza B; Murphy GF; Gomes C; Liu C; Moss EL; Falconer SB; Bhatt AS; Taur Y; Pamer EG; van den Brink MRM; Jenq RR
    Sci Transl Med; 2016 May; 8(339):339ra71. PubMed ID: 27194729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in Taiwan.
    Huang YC; Hsiao FY; Guan ST; Yao M; Liu CJ; Chen TT; Lin TL; Liu YC; Chen TY; Hong YC; Ma MC; Tan TD; Wang CC; Wu YY; Liao PW; Wu YF; Chen YY; Yu YB; Hsieh YY; Lee MY; Liu JH; Lin SW; Ko BS
    J Microbiol Immunol Infect; 2024 Jun; 57(3):365-374. PubMed ID: 38503632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of 14 patients aged ≤ 50 years with high-risk multiple myeloma treated with allogeneic hematopoietic stem cell transplantation].
    Pan P; Wang JL; Zhai WH; Ma QL; Yang DL; Feng SZ; Han MZ; Pang AM; Jiang EL
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):28-34. PubMed ID: 38527835
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
    Ganetsky A; Han JH; Hughes ME; Babushok DV; Frey NV; Gill SI; Hexner EO; Loren AW; Luger SM; Mangan JK; Martin ME; Smith J; Freyer CW; Gilmar C; Schuster M; Stadtmauer EA; Porter DL
    Clin Infect Dis; 2019 May; 68(12):2003-2009. PubMed ID: 30256954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of early cyclosporine A levels on acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation using in vivo T-cell depletion.
    Nikoloudis A; Buxhofer-Ausch V; Aichinger C; Binder M; Hasengruber P; Kaynak E; Wipplinger D; Milanov R; Strassl I; Stiefel O; Machherndl-Spandl S; Petzer A; Weltermann A; Clausen J
    Cytotherapy; 2024 May; 26(5):490-497. PubMed ID: 38385908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Bloodstream Infections after Hematopoietic Stem Cell Transplantation for Hurler Syndrome.
    Dunseath C; O'Connor G; Mahulkar S; Badia P; Koo J; Dandoy CE
    Transplant Cell Ther; 2023 Nov; 29(11):707.e1-707.e4. PubMed ID: 37582469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective treatment of Clostridioides difficile infection improves survival and affects graft-versus-host disease: a multicenter study by the Polish Adult Leukemia Group.
    Piekarska A; Sadowska-Klasa A; Mensah-Glanowska P; Sobczyk-Kruszelnicka M; Drozd-Sokołowska J; Waszczuk-Gajda A; Kujawska J; Wilk M; Tomaszewska A; Zaucha JM; Giebel S; Gil L
    Sci Rep; 2024 Mar; 14(1):5947. PubMed ID: 38467719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of sirolimus as an alternative GVHD prophylaxis for patients with kidney injury undergoing allo-HSCT].
    Sun W; Ma R; He Y; Bai L; Chen YY; Chen Y; Zhang YY; Wang JZ; Chen H; Zhang XH; Xu LP; Wang Y; Huang XJ; Sun YQ
    Zhonghua Nei Ke Za Zhi; 2023 Dec; 62(12):1444-1450. PubMed ID: 38044071
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-viral pathogens of infectious diarrhoea post-allogeneic stem cell transplantation are associated with graft-versus-host disease.
    Rees MJ; Rivalland A; Tan S; Xie M; Yong MK; Ritchie D
    Ann Hematol; 2024 Feb; 103(2):593-602. PubMed ID: 37926752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, Microbiology, and Risk Factors of Bacterial Bloodstream Infections in Patients After Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang R; Xiong Y; Zhang L; Liu L
    Infect Drug Resist; 2024; 17():1561-1569. PubMed ID: 38660056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between human leukocyte antigens and graft-versus-host disease occurrence after allogenic hematopoietic stem cell transplantation.
    Cardozo DM; Lieber SR; Marques SB; Aranha FJ; Vigorito AC; Souza CA; Visentainer JE
    Sao Paulo Med J; 2012; 130(4):219-24. PubMed ID: 22965361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of FOXP3 Single Nucleotide Polymorphisms With Clinical Outcomes After Allogenic Hematopoietic Stem Cell Transplantation.
    Nam M; Shin S; Park KU; Kim I; Yoon SS; Kwon TK; Song EY
    Ann Lab Med; 2018 Nov; 38(6):591-598. PubMed ID: 30027704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota trajectory in β-thalassemia major children who underwent allogeneic hematopoietic stem cell transplantation.
    Luo H; Liu T; Qu Y; Kuang C; Xiao M; Sun J; Chen H; Wu J; Liu X; Jiang H
    Transpl Infect Dis; 2023 Oct; 25(5):e14111. PubMed ID: 37615262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.
    Shono Y; van den Brink MRM
    Nat Rev Cancer; 2018 May; 18(5):283-295. PubMed ID: 29449660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.
    Sorror ML; Martin PJ; Storb RF; Bhatia S; Maziarz RT; Pulsipher MA; Maris MB; Davis C; Deeg HJ; Lee SJ; Maloney DG; Sandmaier BM; Appelbaum FR; Gooley TA
    Blood; 2014 Jul; 124(2):287-95. PubMed ID: 24797298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell Transplantation.
    Siblany L; Stocker N; Ricard L; Brissot E; Duléry R; Banet A; Sestili S; Belhocine R; Van de Wyngaert Z; Bonnin A; Capes A; Ledraa T; Beurier P; Fadel K; Mohty M; Gaugler B; Malard F
    J Clin Immunol; 2024 Jun; 44(6):139. PubMed ID: 38822857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.